GW597599

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW597599, covering 2017-07-11 to 2017-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia [Phase 2]